Efalizumab: ¿un tratamiento seguro para una enfermedad crónica?
Is efalizumab: a safe treatment for a chronic disease?
Read
24574
Timeswas read the article
10858
Total PDF
13716
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 57 | 112 | 169 |
| 2025 5 | 69 | 64 | 133 |
| 2025 4 | 65 | 57 | 122 |
| 2025 3 | 70 | 28 | 98 |
| 2025 2 | 123 | 38 | 161 |
| 2025 1 | 100 | 56 | 156 |
| 2024 12 | 112 | 45 | 157 |
| 2024 11 | 109 | 62 | 171 |
| 2024 10 | 70 | 45 | 115 |
| 2024 9 | 50 | 30 | 80 |
| 2024 8 | 93 | 71 | 164 |
| 2024 7 | 81 | 39 | 120 |
| 2024 6 | 79 | 44 | 123 |
| 2024 5 | 74 | 35 | 109 |
| 2024 4 | 77 | 40 | 117 |
| 2024 3 | 44 | 23 | 67 |
| 2024 2 | 74 | 44 | 118 |
| 2024 1 | 73 | 32 | 105 |
| 2023 12 | 72 | 24 | 96 |
| 2023 11 | 102 | 35 | 137 |
| 2023 10 | 49 | 29 | 78 |
| 2023 9 | 79 | 28 | 107 |
| 2023 8 | 76 | 28 | 104 |
| 2023 7 | 86 | 48 | 134 |
| 2023 6 | 62 | 45 | 107 |
| 2023 5 | 47 | 45 | 92 |
| 2023 4 | 66 | 66 | 132 |
| 2023 3 | 71 | 43 | 114 |
| 2023 2 | 58 | 37 | 95 |
| 2023 1 | 48 | 38 | 86 |
| 2022 12 | 45 | 44 | 89 |
| 2022 11 | 66 | 51 | 117 |
| 2022 10 | 60 | 42 | 102 |
| 2022 9 | 48 | 92 | 140 |
| 2022 8 | 48 | 41 | 89 |
| 2022 7 | 54 | 42 | 96 |
| 2022 6 | 46 | 34 | 80 |
| 2022 5 | 66 | 48 | 114 |
| 2022 4 | 45 | 47 | 92 |
| 2022 3 | 51 | 60 | 111 |
| 2022 2 | 56 | 44 | 100 |
| 2022 1 | 79 | 79 | 158 |
| 2021 12 | 74 | 72 | 146 |
| 2021 11 | 53 | 40 | 93 |
| 2021 10 | 66 | 60 | 126 |
| 2021 9 | 57 | 48 | 105 |
| 2021 8 | 52 | 30 | 82 |
| 2021 7 | 44 | 37 | 81 |
| 2021 6 | 27 | 32 | 59 |
| 2021 5 | 46 | 44 | 90 |
| 2021 4 | 106 | 46 | 152 |
| 2021 3 | 57 | 36 | 93 |
| 2021 2 | 66 | 27 | 93 |
| 2021 1 | 48 | 31 | 79 |
| 2020 12 | 36 | 21 | 57 |
| 2020 11 | 30 | 22 | 52 |
| 2020 10 | 34 | 16 | 50 |
| 2020 9 | 41 | 12 | 53 |
| 2020 8 | 45 | 15 | 60 |
| 2020 7 | 28 | 20 | 48 |
| 2020 6 | 31 | 11 | 42 |
| 2020 5 | 39 | 13 | 52 |
| 2020 4 | 35 | 16 | 51 |
| 2020 3 | 55 | 15 | 70 |
| 2020 2 | 5 | 2 | 7 |
| 2020 1 | 0 | 2 | 2 |
| 2019 9 | 0 | 2 | 2 |
| 2019 7 | 0 | 4 | 4 |
| 2019 6 | 0 | 13 | 13 |
| 2019 5 | 0 | 38 | 38 |
| 2019 4 | 0 | 16 | 16 |
| 2019 3 | 0 | 2 | 2 |
| 2019 2 | 0 | 4 | 4 |
| 2018 12 | 0 | 2 | 2 |
| 2018 10 | 0 | 4 | 4 |
| 2018 9 | 1 | 1 | 2 |
| 2018 8 | 0 | 6 | 6 |
| 2018 7 | 0 | 2 | 2 |
| 2018 6 | 0 | 5 | 5 |
| 2018 5 | 0 | 7 | 7 |
| 2018 4 | 0 | 1 | 1 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 18 | 13 | 31 |
| 2018 1 | 20 | 6 | 26 |
| 2017 12 | 20 | 7 | 27 |
| 2017 11 | 23 | 15 | 38 |
| 2017 10 | 13 | 5 | 18 |
| 2017 9 | 11 | 15 | 26 |
| 2017 8 | 12 | 31 | 43 |
| 2017 7 | 9 | 28 | 37 |
| 2017 6 | 23 | 29 | 52 |
| 2017 5 | 19 | 8 | 27 |
| 2017 4 | 17 | 14 | 31 |
| 2017 3 | 14 | 22 | 36 |
| 2017 2 | 16 | 13 | 29 |
| 2017 1 | 16 | 8 | 24 |
| 2016 12 | 27 | 3 | 30 |
| 2016 11 | 45 | 7 | 52 |
| 2016 10 | 36 | 6 | 42 |
| 2016 9 | 32 | 5 | 37 |
| 2016 8 | 29 | 10 | 39 |
| 2016 7 | 19 | 5 | 24 |
| 2016 6 | 11 | 9 | 20 |
| 2016 5 | 10 | 13 | 23 |
| 2016 4 | 20 | 8 | 28 |
| 2016 3 | 18 | 9 | 27 |
| 2016 2 | 8 | 9 | 17 |
| 2016 1 | 20 | 27 | 47 |
| 2015 12 | 4 | 15 | 19 |
| 2015 11 | 13 | 16 | 29 |
| 2015 10 | 7 | 17 | 24 |
| 2015 9 | 49 | 4 | 53 |
| 2015 8 | 57 | 4 | 61 |
| 2015 7 | 258 | 3 | 261 |
| 2015 6 | 238 | 284 | 522 |
| 2015 5 | 324 | 396 | 720 |
| 2015 4 | 332 | 373 | 705 |
| 2015 3 | 238 | 304 | 542 |
| 2015 2 | 246 | 339 | 585 |
| 2015 1 | 215 | 217 | 432 |
| 2014 12 | 284 | 214 | 498 |
| 2014 11 | 286 | 247 | 533 |
| 2014 10 | 345 | 378 | 723 |
| 2014 9 | 369 | 357 | 726 |
| 2014 8 | 327 | 338 | 665 |
| 2014 7 | 409 | 431 | 840 |
| 2014 6 | 444 | 304 | 748 |
| 2014 5 | 458 | 348 | 806 |
| 2014 4 | 332 | 324 | 656 |
| 2014 3 | 327 | 237 | 564 |
| 2014 2 | 220 | 174 | 394 |
| 2014 1 | 318 | 247 | 565 |
| 2013 12 | 344 | 212 | 556 |
| 2013 11 | 192 | 177 | 369 |
| 2013 10 | 329 | 248 | 577 |
| 2013 9 | 187 | 218 | 405 |
| 2013 8 | 211 | 251 | 462 |
| 2013 7 | 252 | 247 | 499 |
| 2013 6 | 219 | 195 | 414 |
| 2013 5 | 94 | 143 | 237 |
| 2013 4 | 99 | 78 | 177 |
| 2013 3 | 132 | 49 | 181 |
| 2013 2 | 154 | 83 | 237 |
| 2013 1 | 112 | 99 | 211 |
| 2012 12 | 98 | 63 | 161 |
| 2012 11 | 84 | 60 | 144 |
| 2012 10 | 83 | 69 | 152 |
| 2012 9 | 56 | 33 | 89 |
| 2012 8 | 10 | 6 | 16 |
| 2012 7 | 1 | 0 | 1 |
| 2011 3 | 1 | 0 | 1 |
| 2011 2 | 6 | 0 | 6 |
| 2011 1 | 6 | 0 | 6 |
| 2010 12 | 3 | 0 | 3 |
| 2010 11 | 46 | 0 | 46 |
| 2010 10 | 49 | 0 | 49 |
| 2010 9 | 44 | 0 | 44 |
| 2010 8 | 45 | 0 | 45 |
| 2010 7 | 8 | 0 | 8 |
| 2010 6 | 17 | 0 | 17 |
| 2010 5 | 22 | 0 | 22 |
| 2010 4 | 18 | 0 | 18 |
| 2010 2 | 2 | 0 | 2 |
| 2009 11 | 2 | 0 | 2 |
| 2009 9 | 10 | 0 | 10 |
| 2009 8 | 5 | 0 | 5 |
| 2009 7 | 10 | 0 | 10 |
| 2009 6 | 12 | 0 | 12 |
| 2009 5 | 3 | 0 | 3 |
| 2009 4 | 7 | 0 | 7 |
| 2009 3 | 9 | 0 | 9 |
| 2008 9 | 5 | 0 | 5 |
| 2008 8 | 17 | 0 | 17 |
| 2008 7 | 34 | 0 | 34 |
| 2008 6 | 40 | 0 | 40 |
| 2008 5 | 54 | 0 | 54 |
| 2008 4 | 1 | 0 | 1 |
Show all
